Complementing randomised clinical trials (RCT) with real world data/evidence (RWD/RWE) is rapidly evolving from concept to adoption in pharma development. Recent regulatory guidance is encouraging further exploration and integration of eSources. Developing data standards and interface enablement are underpinning this trend. This in turn allows for more pragmatic clinical trials (PCT) which can provide timely and better decision support for patient management.
Speakers and panellists will discuss opportunities and challenges with access to RWE, design of PCT, and the future of clinical trials.
Chairperson: Dr Jon Carrano, Managing Director, Pharmsite